13th Feb 2012 16:55
13 February 2012
Barclays PLC
Director/PDMR shareholding: Disclosure and Transparency Rules 3.1.4R(1)(a)
On 10 February 2012 the following ordinary shares in Barclays PLC ("the Company") were purchased on behalf of the following non-executive Directors of the Company at a price of £2.3801 per share on the London Stock Exchange. As disclosed in the Company's Annual Report, these purchases arise from the policy of using part of each non-executive Director's fee to purchase shares in the Company on the Directors' behalf which, together with any reinvested dividends, are retained for the Director until they leave the Board.
DIRECTOR
|
BARCLAYS PLC SHARES PURCHASED | TOTAL BENEFICIAL INTEREST FOLLOWING THIS NOTIFICATION | TOTAL NON-BENEFICIAL INTEREST FOLLOWING THIS NOTIFICATION
|
David Booth | 3,939 | 86,806 | - |
Alison Carnwath | 3,004 | 47,742 | - |
Fulvio Conti | 3,955 | 52,455 | - |
Simon Fraser | 3,630 | 83,144 | - |
Reuben Jeffery¹ | 5,009 | 77,183 | - |
Sir Andrew Likierman | 3,357 | 35,686 | - |
Dambisa Moyo | 3,631 | 11,429 | - |
Sir Michael Rake | 3,165 | 38,378 | - |
Sir John Sunderland | 3,129 | 91,187 | - |
¹ Reuben Jeffery's beneficial interest comprises 15,000 American Depositary Shares and 7,691 Ordinary Shares in Barclays PLC
Related Shares:
Barclays